Cell Growth & Differentiation, Vol 7, Issue 10 1383-1392, Copyright © 1996 by American Association of Cancer Research

ARTICLES

Complex regulation of human c-kit transcription by promoter repressors, activators, and specific myb elements

GR Vandenbark, Y Chen, E Friday, K Pavlik, B Anthony, C deCastro and RE Kaufman
Department of Medicine, Louisiana State University Medical Center, Shreveport 71130-3932, USA.

The c-kit proto-oncogene is expressed in several tissues during development. To understand the mechanisms controlling the expression of this gene, we characterized the human c-kit promoter. Expression is controlled transcriptionally. The 5'-flanking DNA was used to make promoter deletion-reporter constructs that were tested in cells that were either positive or negative for endogenous c-Kit. The results demonstrate that DNA, to at least position -4100, directs transcription well in both positive and negative cells. Addition of DNA from position -4100 to -5500 causes a reduction in expression to near-basal levels in c-Kit-negative cells but has little effect in c-Kit-positive cells. The DNA from -4100 to -5500 was tested for repressor function. It inhibits transcription from some heterologous promoters in c-Kit-negative cells. Likewise, this segment inhibits transcription from the homologous proximal promoter in a cell-specific manner, but the entire promoter is necessary for complete repression in c-Kit-negative cells. Two Myb binding motifs were also identified, and their role in regulating transcription was examined by mutation and functional testing. One, MYB1, acts as a partial repressor, whereas the other, MYB2, is a positive element that appears essential for expression. Binding proteins to both sites were characterized by several methods. MYB1 binds and responds functionally to c-Myb, but MYB2 does not. The results of these studies indicate that the regulation of c-kit transcription is complex, involving interactions among several activators and repressors.

This article has been cited by other articles:

				W. Zhao, G. Gomez, S.-H. Yu, J. J. Ryan, and L. B. Schwartz TGF-{beta}1 Attenuates Mediator Release and De Novo Kit Expression by Human Skin Mast Cells through a Smad-Dependent Pathway J. Immunol., November 15, 2008; 181(10): 7263 - 7272. [Abstract] [Full Text] [PDF]

				Y. Nakata, S. Shetzline, C. Sakashita, A. Kalota, R. Rallapalli, S. I. Rudnick, Y. Zhang, S. G. Emerson, and A. M. Gewirtz c-Myb Contributes to G2/M Cell Cycle Transition in Human Hematopoietic Cells by Direct Regulation of Cyclin B1 Expression Mol. Cell. Biol., March 15, 2007; 27(6): 2048 - 2058. [Abstract] [Full Text] [PDF]

				S. E. Shetzline, R. Rallapalli, K. J. Dowd, S. Zou, Y. Nakata, C. R. Swider, A. Kalota, J. K. Choi, and A. M. Gewirtz Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias Blood, September 15, 2004; 104(6): 1833 - 1840. [Abstract] [Full Text] [PDF]

				X.-M. You, I. N. Mungrue, W. Kalair, T. Afroze, B. Ravi, A. M. Sadi, R. Gros, and M. Husain Conditional Expression of a Dominant-Negative c-Myb in Vascular Smooth Muscle Cells Inhibits Arterial Remodeling After Injury Circ. Res., February 21, 2003; 92(3): 314 - 321. [Abstract] [Full Text] [PDF]

				L. Vitelli, G. Condorelli, V. Lulli, T. Hoang, L. Luchetti, C. M. Croce, and C. Peschle A Pentamer Transcriptional Complex Including tal-1 and Retinoblastoma Protein Downmodulates c-kit Expression in Normal Erythroblasts Mol. Cell. Biol., July 15, 2000; 20(14): 5330 - 5342. [Abstract] [Full Text]

				T. Afroze and M. Husain c-Myb-binding Sites Mediate G1/S-associated Repression of the Plasma Membrane Ca2+-ATPase-1 Promoter J. Biol. Chem., March 17, 2000; 275(12): 9062 - 9069. [Abstract] [Full Text] [PDF]

				M. Schmidt, V. Nazarov, L. Stevens, R. Watson, and L. Wolff Regulation of the Resident Chromosomal Copy of c-myc by c-Myb Is Involved in Myeloid Leukemogenesis Mol. Cell. Biol., March 15, 2000; 20(6): 1970 - 1981. [Abstract] [Full Text]

				M. von Lindern, W. Zauner, G. Mellitzer, P. Steinlein, G. Fritsch, K. Huber, B. Lowenberg, and H. Beug The Glucocorticoid Receptor Cooperates With the Erythropoietin Receptor and c-Kit to Enhance and Sustain Proliferation of Erythroid Progenitors In Vitro Blood, July 15, 1999; 94(2): 550 - 559. [Abstract] [Full Text] [PDF]

				G. H. Park, H. K. Plummer III, and G. W. Krystal Selective Sp1 Binding Is Critical for Maximal Activity of the Human c-kit Promoter Blood, December 1, 1998; 92(11): 4138 - 4149. [Abstract] [Full Text] [PDF]

				A. M. Gewirtz, D. L. Sokol, and M. Z. Ratajczak Nucleic Acid Therapeutics: State of the Art and Future Prospects Blood, August 1, 1998; 92(3): 712 - 736. [Full Text] [PDF]

				M. Z. Ratajczak, D. Perrotti, P. Melotti, M. Powzaniuk, B. Calabretta, K. Onodera, D. A. Kregenow, B. Machalinski, and A. M. Gewirtz Myb and Ets Proteins Are Candidate Regulators of c-kit Expression in Human Hematopoietic Cells Blood, March 15, 1998; 91(6): 1934 - 1946. [Abstract] [Full Text] [PDF]

				J. He, C. M. deCastro, G. R. Vandenbark, J. Busciglio, and D. Gabuzda Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protooncogene PNAS, April 15, 1997; 94(8): 3954 - 3959. [Abstract] [Full Text] [PDF]

				J. Coffman, C. Kirchhamer, M. Harrington, and E. Davidson SpMyb functions as an intramodular repressor to regulate spatial expression of CyIIIa in sea urchin embryos Development, January 12, 1997; 124(23): 4717 - 4727. [Abstract] [PDF]